Zu lab Publications


T-cell lymphoma secondary to checkpoint inhibitor therapy
Anand, K, Ensor, Jr. JE, Pingali, SR, Hwu, P, Duvic, M, Chiang, S, Miranda, R, Zu, Y & Iyer, S 2020, Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, e000104. https://doi.org/10.1136/jitc-2019-000104

Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer Probe
Liu, Y, Jiang, W, Yang, S, Hu, J, Lu, H, Han, W, Wen, J, Zeng, Z, Qi, J, Xu, L, Zhou, H, Sun, H & Zu, Y 2019, ACS Sensors, vol. 4, no. 8, pp. 2028-2038. https://doi.org/10.1021/acssensors.9b00582

Tracking biodistribution of myeloid-derived cells in murine models of breast cancer
Li, J, Mai, J, Hinkle, L, Lin, D, Zhang, J, Liu, X, Ramirez, MR, Zu, Y, Lokesh, GL, Volk, DE & Shen, H 2019, Genes, vol. 10, no. 4, 297. https://doi.org/10.3390/genes10040297

ALK phosphorylates SMAD4 on tyrosine to disable TGF-ß tumour suppressor functions
Zhang, Q, Xiao, M, Gu, S, Xu, Y, Liu, T, Li, H, Yu, Y, Qin, L, Zhu, Y, Chen, F, Wang, Y, Ding, C, Wu, H, Ji, H, Chen, Z, Zu, Y, Malkoski, S, Li, Y, Liang, T, Ji, J, Qin, J, Xu, P, Zhao, B, Shen, L, Lin, X & Feng, XH 2019, Nature Cell Biology, vol. 21, no. 2, pp. 179-189. https://doi.org/10.1038/s41556-018-0264-3

Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy
Yang, S, Wen, J, Li, H, Xu, L, Liu, Y, Zhao, N, Zeng, Z, Qi, J, Jiang, W, Han, W & Zu, Y 2019, Small. https://doi.org/10.1002/smll.201900903

High-Throughput Isolation of Cell Protrusions with Single-Cell Precision for Profiling Subcellular Gene Expression
Zhang, P, Han, X, Yao, J, Shao, N, Zhang, K, Zhou, Y, Zu, Y, Wang, B & Qin, L 2019, Angewandte Chemie - International Edition. https://doi.org/10.1002/anie.201903694

Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
Yang, S, Li, H, Xu, L, Deng, Z, Han, W, Liu, Y, Jiang, W & Zu, Y 2018, Molecular Therapy - Nucleic Acids, vol. 13, pp. 164-175. https://doi.org/10.1016/j.omtn.2018.08.023

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Wang, X, Cao, X, Sun, R, Tang, C, Tzankov, A, Zhang, J, Manyam, GC, Xiao, M, Miao, Y, Jabbar, K, Tan, X, Pang, Y, Visco, C, Xie, Y, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, van Krieken, JH, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Piris, MA, Li, S, Miranda, RN, Medeiros, LJ, Li, Y, Xu-Monette, ZY & Young, KH 2018, Neoplasia (United States), vol. 20, no. 6, pp. 574-593. https://doi.org/10.1016/j.neo.2018.03.002

DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement
Mai, J, Li, X, Zhang, G, Huang, Y, Xu, R, Shen, Q, Lokesh, GL, Thiviyanathan, V, Chen, L, Liu, H, Zu, Y, Ma, X, Volk, DE, Gorenstein, DG, Ferrari, M & Shen, H 2018, Molecular Pharmaceutics, vol. 15, no. 5, pp. 1814-1825. https://doi.org/10.1021/acs.molpharmaceut.7b01169

Tumor-specific t-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed hodgkin lymphoma
Bollard, CM, Tripic, T, Cruz, CR, Dotti, G, Gottschalk, S, Torrano, V, Dakhova, O, Carrum, G, Ramos, CA, Liu, H, Wu, MF, Marcogliese, AN, Barese, C, Zu, Y, Lee, DY, O’Connor, O, Gee, AP, Brenner, M, Heslop, H & Rooney, CM 2018, Journal of Clinical Oncology, vol. 36, no. 11, pp. 1128-1139. https://doi.org/10.1200/JCO.2017.74.3179

A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells
Liu, H, Mai, J, Shen, J, Wolfram, J, Li, Z, Zhang, G, Xu, R, Li, Y, Mu, C, Zu, Y, Li, X, Lokesh, GL, Thiviyanathan, V, Volk, DE, Gorenstein, DG, Ferrari, M, Hu, Z & Shen, H 2018, Theranostics, vol. 8, no. 1, pp. 31-44. https://doi.org/10.7150/thno.21342

Updates in Polycythemia Vera
Nagrale, V, Olsen, RJ & Zu, Y 2018, . in C-CJ Chang & R Ohgami (eds), Precision Molecular Pathology of Myeloid Neoplasms. 1st edn, vol. 12, Springer, Switzerland, pp. 115-139. https://doi.org/10.1007/978-3-319-62146-3

Spin-Valve based magnetoresistive nanoparticle detector for applications in biosensing
Qiu, W, Chang, L, Liang, YC, Litvinov, J, Guo, J, Chen, YT, Vu, B, Kourentzi, K, Xu, S, Lee, TR, Zu, Y, Willson, RC & Litvinov, D 2017, Sensors and Actuators, A: Physical, vol. 265, pp. 174-180. https://doi.org/10.1016/j.sna.2017.08.018

Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry
Wang, HY & Zu, Y 2017, Archives of Pathology and Laboratory Medicine, vol. 141, no. 9, pp. 1236-1246. https://doi.org/10.5858/arpa.2016-0521-RA


Ultrasensitive magnetic nanoparticle detector for biosensor applications
Liang, YC, Chang, L, Qiu, W, Kolhatkar, AG, Vu, B, Kourentzi, K, Lee, TR, Zu, Y, Willson, RC & Litvinov, D 2017, Sensors (Switzerland), vol. 17, no. 6, 1296. https://doi.org/10.3390/s17061296

Aptamer internalization via endocytosis inducing s-phase arrest and priming maver-1 lymphoma cells for cytarabine chemotherapy
Li, H, Yang, S, Yu, G, Shen, L, Fan, J, Xu, L, Zhang, H, Zhao, N, Zeng, Z, Hu, T, Wen, J & Zu, Y 2017, Theranostics, vol. 7, no. 5, pp. 1204-1213. https://doi.org/10.7150/thno.17069


Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma
Xu-Monette, ZY, Li, L, Byrd, JC, Jabbar, KJ, Manyam, GC, De Winde, CM, Van Den Brand, M, Tzankov, A, Visco, C, Wang, J, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Wang, M, Hagemeister, FB, Piris, MA, Van Krieken, JH, Medeiros, LJ, Li, Y, Van Spriel, AB & Young, KH 2016, Blood, vol. 128, no. 26, pp. 3083-3100. https://doi.org/10.1182/blood-2016-05-715094

B7-H4 expression in ovarian serous carcinoma: a study of 306 cases
Liang, L, Jiang, Y, Chen, JS, Niu, N, Piao, J, Ning, J, Zu, Y, Zhang, J & Liu, J 2016, Human pathology, vol. 57, pp. 1-6. https://doi.org/10.1016/j.humpath.2016.06.011

Live Chat Available